AKBA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: AKBA Shares Outstanding History and AKBA YTD Return |
AKBA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: AKBA Shares Outstanding History and AKBA YTD Return |
AKBA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-9.41% CAGR Mouse over chart for data details
|
AKBA Stock Price Chart |
About Akebia Therapeutics Inc |
Akebia Therapeutics is a biopharmaceutical company. Co.'s portfolio includes a late-stage product candidate and a commercial product: Vadadustat, which is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor designed to mimic the physiologic effect of altitude on oxygen availability; and Auryxia® (ferric citrate), which is approved and marketed in the U.S. for two indications which are the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis or the Hyperphosphatemia Indication, and the treatment of iron deficiency anemia (IDA) in adult patients with CKD not on dialysis or the IDA Indication. We show 39 historical shares outstanding datapoints in our AKBA shares outstanding history coverage, used to compute AKBA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AKBA market cap history over the course of time is important for investors interested in comparing AKBA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AKBA versus a peer is one thing; comparing AKBA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AKBA can fluctuate over the course of history. With this page we aim to empower investors researching AKBA by allowing them to research the AKBA market cap history. |
AKBA Current Stock Quote |
Free AKBA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
AKBA Share Performance |
Market Cap Peers |
Akebia Therapeutics (AKBA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AKCA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.